Clinical Trials
All Clinical Trials - Page 35 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04194125Phase 2Unknown
Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer
Octreotide
- NCT03668470Phase 2Completed
Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
Dulaglutide
- NCT02889393Phase 2Completed
Teduglutide for Enterocutaneous Fistula (ECF)
Teduglutide
- NCT03826160N/ACompleted
Growth Hormone Dynamics and Cardiac Steatosis in HIV
Tesamorelin
- NCT03741517N/AUnknown
Biomarker Study of Pancreatic Neuroendocrine Tumours
Octreotide
- NCT03823339N/ACompleted
A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
Liraglutide
- NCT02789878Phase 2Completed
Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer
Gonadorelin
- NCT04535960Phase 2Unknown
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
Liraglutide
- NCT03847207Phase 1Completed
A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310
Desmopressin
- NCT03811574Phase 3Completed
STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
Semaglutide
- NCT03885297N/ACompleted
3mg Liraglutide for Overweight or Obesity
Liraglutide
- NCT03789578Phase 1Completed
A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
Semaglutide
- NCT03375788Phase 2Completed
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Tesamorelin
- NCT03442972Phase 2/Phase 3Completed
Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral Lipids
Teduglutide
- NCT03737240Phase 3Completed
IDegLira HIGH Trial
Liraglutide
- NCT03087032Phase 4Recruiting
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
Liraglutide
- NCT04046822Phase 4Unknown
Effect of Liraglutide on Microbiome in Obesity
Liraglutide
- NCT03795701N/ACompleted
To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
Liraglutide
- NCT03799198Phase 4Completed
Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity
Liraglutide
- NCT04371991N/ACompleted
Kisspeptin Levels in Early Pregnancy
Kisspeptin
- NCT03916640Phase 1Completed
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
Pramlintide
- NCT03659682Phase 2Unknown
GLP1R in Parkinson's Disease
Semaglutide
- NCT03590626N/ACompleted
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Dulaglutide
- NCT03812939N/AUnknown
Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs
Octreotide
- NCT04916665N/ACompleted
Bridging Intestinal Failure With Teduglutide - a Case Report
Teduglutide
- NCT03959865N/AUnknown
GLP-1 REceptor Agonists and Real World EvIdeNce
Liraglutide
- NCT03541447Phase 2Completed
Tolvaptan-Octreotide LAR Combination in ADPKD
Octreotide
- NCT03867357N/ACompleted
Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia
Gonadorelin
- NCT03630666N/AActive Not Recruiting
Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients
Gonadorelin
- NCT03712098Phase 2Completed
Daily Liraglutide for Nicotine Dependence
Liraglutide
- NCT03757130Phase 1Completed
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
Liraglutide
- NCT03746522Phase 3Completed
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity
Setmelanotide
- NCT03730662Phase 3Completed
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Tirzepatide
- NCT04190160N/ACompleted
Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
Liraglutide
- NCT03713684Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
Efpeglenatide
- NCT03057509Phase 1Withdrawn
A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors
Octreotide
- NCT03628066Phase 2Completed
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Gonadorelin
- NCT03724981Phase 4Completed
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Semaglutide
- NCT03707990Phase 1Completed
A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
Semaglutide
- NCT03724409EARLY_Phase 1Terminated
Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
Octreotide
- NCT03702140Phase 2Unknown
Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy
Teriparatide
- NCT03819790Phase 4Completed
The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
Lixisenatide
- NCT03689374Phase 3Completed
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
Semaglutide
- NCT03993132N/ACompleted
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
Liraglutide
- NCT03707171Phase 3Completed
Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT03720886Phase 1/Phase 2Unknown
G56W1 in Women With Postmenopausal Osteoporosis
Teriparatide
- NCT03756116N/AUnknown
Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide
Octreotide
- NCT03480022Phase 3Completed
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
Liraglutide
- NCT03684642Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Dulaglutide
- NCT03440879N/ATerminated
Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose
Gonadorelin